Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and antiviral agents. Its halogenated pyrimidine structure allows for selective cross-coupling reactions, enabling the introduction of fluorinated aromatic systems in drug candidates. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the electron-withdrawing effects of fluorine and the reactivity of the bromo group. Also utilized in the preparation of agrochemicals and functional materials where fluorinated heterocycles enhance stability and bioavailability.